Sustainability momentum Intersurgical has achieved a significant sustainability uplift, earning an EcoVadis Bronze Medal with a 30% score increase in 2026, and ranking in the top 35% globally and top 10% in its industry. This positions the company as a credible partner for customers prioritizing ESG criteria and sustainable sourcing.

Strategic acquisitions The proposed acquisition of Teleflex’s Acute Care and Interventional Urology units for about $530M indicates rapid expansion into higher-value clinical markets and broader product solutions, presenting cross-sell opportunities to existing customers and entering new care pathways.

Broad clinical portfolio With offerings spanning airway management, anaesthesia, critical care, and oxygen and aerosol therapy, Intersurgical serves prehospital, hospital, and home care settings, enabling multi-category selling to hospitals, ambulatory centers, and home healthcare providers.

Regional expansion Expansion activity in Lithuania’s Pabradė facility with a €10 million investment signals capacity growth and near-term production scale-up, creating potential for new regional contracts, improved lead times, and dual-sourcing opportunities for customers in Europe.

Mid-market growth driver Revenue is reported between $500 million and $1 billion with a mid-to-large employee base, placing Intersurgical as a strong mid-market player similar to peers like ResMed and Ottobock, suggesting targeted sales plays to hospitals upgrading respiratory care and ambulatory services.